杜皮鲁玛
医学
哮喘
单克隆抗体
单克隆
内科学
临床疗效
白细胞介素
免疫学
抗体
细胞因子
作者
Mario Castro,Jonathan Corren,Ian Pavord,Jorge Máspero,Sally E. Wenzel,Klaus F. Rabe,William W. Busse,Linda Ford,Lawrence Sher,J. Mark FitzGerald,Constance H. Katelaris,Yuji Tohda,Bingzhi Zhang,Heribert Staudinger,Gianluca Pirozzi,Nikhil Amin,Marcella Ruddy,Bolanle Akinlade,Asif Khan,Jingdong Chao
标识
DOI:10.1056/nejmoa1804092
摘要
Dupilumab is a fully human anti–interleukin-4 receptor α monoclonal antibody that blocks both interleukin-4 and interleukin-13 signaling. We assessed its efficacy and safety in patients with uncontrolled asthma.
科研通智能强力驱动
Strongly Powered by AbleSci AI